loader
Please Wait
Applying Filters...

Suanfarma Suanfarma

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Certificates of Suitability (CEPs) for r1_cep_2008_116___rev_02 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Virtual Booth
    Menu

    Neovasc

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PharmaCompass

    Inke S.A: APIs manufacturing plant.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 NEOVASC INC. Richmond CA (1)

    filter

    01 Bovine pericardium (1)

    filter

    01 Canada (1)

    filter

    01 Withdrawn by Holder (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    NEOVASC INC. Richmond CA

    Contact Supplier
      Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
      Post an Enquiry Post an Enquiry
      Flag Canada
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      Bovine pericardium

      PDF Supplier PDF
      URL Supplier Web Content
      R1-CEP 2008-116 - Rev 02
      Withdrawn by Holder
      TSE
      2019-01-21
      2023-12-11
      ASK
      US
      PHARMACOMPASS
      Upload
      your Marketing & Sales content

      Looking for Certificates of Suitability (CEPs) for R1-CEP 2008-116 - Rev 02 of Neovasc Inc. Richmond Ca

      Looking for Certificates of Suitability (CEPs) for R1-CEP 2008-116 - Rev 02 of Neovasc Inc. Richmond Ca 1

      20

      Neovasc Inc. Richmond Ca, based in Canada, is a pharmaceutical company.

      One of their significant offerings is Bovine pericardium, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 2008-116 - Rev 02

      This TSE Type CEP, issued on January 21, 2019, remains in force until December 11, 2023, ensuring its reliability within the pharmaceutical industry.

      Post Enquiry
      POST ENQUIRY